Assia Chemical Industries Ltd.

Assia Chemical Industries Ltd., operating globally as TAPI (Teva Active Pharmaceutical Ingredients), is a leading manufacturer and supplier of active pharmaceutical ingredients (APIs) and contract development and manufacturing organization (CDMO) services for the global pharmaceutical industry. Headquartered in Tel Aviv, Israel, the company features over 85 years of scientific experience, operating 13 manufacturing and regional facilities across Israel, Europe, Asia, and the Americas. Its comprehensive product portfolio includes over 350 high-quality APIs across diverse therapeutic areas such as oncology, cardiovascular, neurology, infectious disease, and endocrinology. TAPI provides specialized custom synthesis, process development, scale-up, and commercial manufacturing across various technical modalities including fermentation, synthetic chemistry, high potent APIs, peptides, and oligonucleotides. As a trusted CDMO partner for pharmaceutical manufacturers worldwide, the company delivers end-to-end support from early R&D concept through commercial production. TAPI operates state-of-the-art global R&D sites and manufacturing plants adhering to strict cGMP, regulatory, and environmental governance standards. Customers can access technical documentation, regulatory updates, and track purchase orders directly through the secure TAPI Connect online portal. Driven by a team of over 4,100 professionals worldwide, TAPI continues to advance global health through high-quality pharmaceutical chemical solutions.